Related Experiment Video
Updated: Jan 30, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Knockdown of ACTA2‑AS1 promotes liver cancer cell proliferation, migration and invasion
1Department of Forensic Surgery, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510700, P.R. China.
Abstract:
Long noncoding RNAs (lncRNAs) are important regulators of various cellular and biological processes. The present study aimed to investigate the functions of a novel lncRNA, ACTA2‑AS1:4, a transcript variant of smooth muscle α‑actin 2‑antisense 1 (ACTA2‑AS1), in regulating liver cancer progression. Expression of lncRNAs in liver cancer tissues and cell lines were analyzed by reverse transcription quantitative polymerase chain reaction (RT‑qPCR). Knockdown of ACTA2‑AS1:4 expression in LM3 liver cancer cells was achieved by transfection with small interfering RNAs (siRNAs) that specifically targeted ACTA2‑AS1:4. The proliferation and cell cycle progression of ACTA2‑AS1:4‑silenced LM3 cells were determined using MTS assay and flow cytometry, respectively. A Transwell system assay was used to evaluate the migration and invasion capacities of LM3 cells transfected with ACTA2‑AS1:4 siRNA. The expression levels of major genes associated with important cellular processes were finally determined by RT‑qPCR and western blot analysis. ACTA2‑AS1:4 expression in liver cancer tissues and multiple cell lines was markedly downregulated by specific siRNAs. This inhibition of ACTA2‑AS1:4 expression significantly promoted the proliferation, cell cycle progression, migration and invasion of LM3 cells. A decrease in ACTA2‑AS1:4 expression also suppressed E‑cadherin expression, increased N‑cadherin expression, decreased caspase 3 expression and increased cyclin D1 and matrix metalloproteinase expression in liver cancer cells. Downregulation of ACTA2‑AS1:4 affects a number of key mechanisms involved in liver cancer progression. These data may be important for the future of liver cancer diagnosis and subsequent treatments.
Insights
The long noncoding RNA ACTA2-AS1:4 is downregulated in liver cancer, promoting tumor progression. Inhibiting this lncRNA accelerates cell proliferation, migration, and invasion, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Long noncoding RNAs (lncRNAs) play crucial roles in cellular functions.
- The specific functions of lncRNA ACTA2-AS1:4 in liver cancer remain largely unexplored.
Purpose of the Study:
- To investigate the role of ACTA2-AS1:4, a variant of ACTA2-AS1, in liver cancer progression.
- To analyze the impact of ACTA2-AS1:4 downregulation on cancer cell behavior and molecular mechanisms.
Main Methods:
- Quantitative reverse transcription PCR (RT-qPCR) to assess lncRNA expression in tissues and cell lines.
- Small interfering RNA (siRNA) to knockdown ACTA2-AS1:4 in LM3 liver cancer cells.
- MTS assay, flow cytometry, Transwell assays, and Western blot to evaluate proliferation, cell cycle, migration, invasion, and gene expression.
Main Results:
- ACTA2-AS1:4 expression was significantly downregulated in liver cancer tissues and cell lines.
- Knockdown of ACTA2-AS1:4 promoted LM3 cell proliferation, cell cycle progression, migration, and invasion.
- Downregulation of ACTA2-AS1:4 altered the expression of key genes including E-cadherin, N-cadherin, caspase 3, cyclin D1, and matrix metalloproteinases.
Conclusions:
- Downregulation of ACTA2-AS1:4 is implicated in liver cancer progression by affecting critical cellular mechanisms.
- These findings suggest ACTA2-AS1:4 may serve as a potential biomarker for liver cancer diagnosis and a therapeutic target.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Cells Coordinate Growth and Proliferation
The Eukaryotic Promoter Region
Abnormal Proliferation

